Back to User profile » Dr Chao Ji
Papers published by Dr Chao Ji:
Predictors of Successful Secukinumab Dose Tapering in Moderate-to-Severe Psoriasis: A Retrospective Study
Chen J, Xiao Z, Zeng X, Xiang N, Luo R, Chen R, Lin B, Ke H, Gong T, Ji C
Psoriasis: Targets and Therapy 2025, 15:527-534
Published Date: 17 October 2025
Proteomic Profiling and Clinical Insights: The Role of MMP9 in Differentiating Psoriasis Vulgaris from Generalized Pustular Psoriasis
Gong T, Chen J, Xiao Z, Luo R, Tong Z, Ke H, Liu Z, Xiao C, Xiang N, Ji C
Journal of Inflammation Research 2025, 18:3795-3805
Published Date: 14 March 2025
Clinical Features of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor versus Non-Immune Checkpoint Inhibitor Drugs in China: A Cross-Sectional Study and Literature Review
Qin K, Gong T, Ruan SF, Lin M, Su X, Lv X, Cheng B, Ji C
Journal of Inflammation Research 2024, 17:7591-7605
Published Date: 22 October 2024
Comparative Efficacy and Safety of Ustekinumab and Secukinumab in the Treatment of Generalized Pustular Psoriasis: A 48-Week Retrospective Cohort Study with Genetic Background Analysis
Ruan SF, Su X, Xiao Z, Zhang Y, Lin T, Luo R, Xiang N, Cheng B, Gong T, Ji C
Journal of Inflammation Research 2024, 17:6707-6721
Published Date: 24 September 2024
Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy
Lin M, Gong T, Ruan S, Lv X, Chen R, Su X, Cheng B, Ji C
Journal of Inflammation Research 2024, 17:2337-2351
Published Date: 17 April 2024
Distinct Proteomic Profiling of Plasma Extracellular Vesicles from Moderate-to-Severe Atopic Dermatitis Patients
Chang CJ, Wang HQ, Zhang J, Zou Y, Zhang YH, Chen JW, Chen CB, Chung WH, Ji C
Clinical, Cosmetic and Investigational Dermatology 2021, 14:1033-1043
Published Date: 25 August 2021